X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (294) 294
female (192) 192
male (180) 180
anemia, hypochromic - chemically induced (173) 173
animals (156) 156
adult (95) 95
anemia (85) 85
middle aged (83) 83
anemia, hypochromic - drug therapy (80) 80
index medicus (73) 73
rats (69) 69
iron - metabolism (61) 61
anemia - chemically induced (47) 47
iron - blood (47) 47
aged (45) 45
anemia, hypochromic - blood (45) 45
anemia, hypochromic - etiology (38) 38
erythropoietin - therapeutic use (37) 37
hematocrit (36) 36
hematology (36) 36
iron (36) 36
hemoglobins - analysis (34) 34
toxicology (33) 33
adolescent (30) 30
iron - therapeutic use (30) 30
mice (30) 30
oncology (30) 30
iron - adverse effects (28) 28
treatment outcome (28) 28
hemoglobins - metabolism (27) 27
recombinant proteins (27) 27
anemia, hemolytic - chemically induced (26) 26
child (25) 25
time factors (25) 25
administration, oral (24) 24
antineoplastic agents - adverse effects (22) 22
toxicity (22) 22
anemia, hypochromic - metabolism (21) 21
dose-response relationship, drug (21) 21
erythropoietin (21) 21
liver - metabolism (21) 21
medicine, general & internal (21) 21
pregnancy (21) 21
anemia, hypochromic - prevention & control (20) 20
blood (20) 20
erythrocyte count (20) 20
erythropoiesis (20) 20
cancer (19) 19
anemia - blood (18) 18
erythropoiesis - drug effects (18) 18
liver - drug effects (18) 18
anemia, hypochromic - complications (17) 17
diet (17) 17
erythropoietin - administration & dosage (17) 17
hematinics - therapeutic use (17) 17
hemoglobin (17) 17
neoplasms - drug therapy (17) 17
anemia - drug therapy (16) 16
anemia - etiology (16) 16
anemia, hypochromic - diagnosis (16) 16
anemia, macrocytic - chemically induced (16) 16
infant (16) 16
iron - administration & dosage (16) 16
iron - deficiency (16) 16
physiological aspects (16) 16
quality of life (16) 16
recombinant-human-erythropoietin (16) 16
body weight - drug effects (15) 15
erythrocytes - drug effects (15) 15
iron deficiency anemia (15) 15
child, preschool (14) 14
erythrocyte indices (14) 14
erythrocytes - metabolism (14) 14
ferritins - blood (14) 14
hemoglobinometry (14) 14
metabolism (14) 14
risk factors (14) 14
thrombocytopenia - chemically induced (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
drug administration schedule (13) 13
hematinics - administration & dosage (13) 13
hematologic diseases - chemically induced (13) 13
intestinal absorption (13) 13
quality-of-life (13) 13
rats, inbred strains (13) 13
renal dialysis - adverse effects (13) 13
article (12) 12
diagnosis, differential (12) 12
endocrinology & metabolism (12) 12
epoetin alfa (12) 12
homeostasis (12) 12
infusions, parenteral (12) 12
iron-dextran complex - adverse effects (12) 12
leukocyte count (12) 12
pharmacology & pharmacy (12) 12
rabbits (12) 12
therapy (12) 12
transferrin (12) 12
transferrin - metabolism (12) 12
aged, 80 and over (11) 11
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (369) 369
German (19) 19
Russian (16) 16
Italian (10) 10
Polish (8) 8
Spanish (7) 7
French (4) 4
Hungarian (4) 4
Japanese (4) 4
Czech (2) 2
Bulgarian (1) 1
Croatian (1) 1
Dutch (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 05/2006, Volume 98, Issue 10, pp. 708 - 714
Journal Article
Theoretical and Applied Genetics, ISSN 0040-5752, 2/2013, Volume 126, Issue 2, pp. 451 - 473
Journal Article
by Canon, Jean-Luc and Vansteenkiste, Johan and Bodoky, György and Mateos, M. Victoria and Bastit, Laurent and Ferreira, Irene and Rossi, Greg and Amado, Rafael G and Stegar, G and Neubauer, A and Aulitzky, W and Peschel, C and Hedenus, M and Hansen, S and Stewrd, W and Emmerich, B and Tomova, A and Malec, V and Frickhofen, N and Cruz, J.J and Bron, D and Pyrhonen, S and Hilgers, W and Bosquée, L and Clemens, M and Nowrousian, M.R and Nobile, F and Honkoop, A.H and Berenschot, H.W.A and Schaafsma, M.R and Gascón, P and Gúrpide, A and Kubista, E and Kornek, G.V and Gattringer, K and Van Droogenbroeck, J and Zachee, P and Hansen, M and Aul, C and Hanauske, A and Korsten, S and Wiedemann, G and Marchetti, P and Iop, A and Hermann, R and Rauch, D and Bargetzi, M and Milligan, D.W and Ferrant, A and Van Eygen, K and Jäger, U and Gunsilius, E and Aapro, M and Wilhelm, M and Brugger, W and Kreuser, E.D and Eckhart, M.J and Brudler, O and Anker Jensen, B and Lindegaard Madsen, E and Lozano, A and Alcala, A and Sierra, J and Lopez, A and Mäenpää, J and Dourthe, L.M and Laplaige, P and Castera, D and Antoine, E and Eikesdal, H.P and Barroso, S and Sanches, E and Birgegård, G and Kramer, M.H.M and Schipperus, M.R and Boogaerts, M and Juvonen, E and Lauri, B and Thaler, J and Sorensen, P and Smakal, M and Koralewski, P and Serwatowski, P and Simova, E and Galova, M and Kuta, M and Wojtukiewicz, M and Kalalejcik, M and Barila, R and Spanik, S and Pintér, T and Bodoky, G and Szántó, J and Leppik, K and Jogi, T and Brize, A and Purkalne, G and Bitina, M and Hotko, E
Journal of the National Cancer Institute, ISSN 0027-8874, 02/2006, Volume 98, Issue 4, pp. 273 - 284
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 142, Issue 6, pp. 1314 - 1323.e1
Recently developed drugs and innovative strategies for the treatment of chronic infection with genotype 1 hepatitis C virus (HCV) have become the standard of... 
Gastroenterology and Hepatology | Boceprevir | Telaprevir | Safety | Triple Therapy | Hepatitis C | HCV RNA | VX-950 | RESISTANCE MUTATIONS | PREVALENCE | PEGINTERFERON | PROTEASE INHIBITOR | COMBINATION TREATMENT | RETREATMENT | GASTROENTEROLOGY & HEPATOLOGY | Recombinant Proteins - therapeutic use | Humans | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Recombinant Proteins - adverse effects | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Serine Proteinase Inhibitors - therapeutic use | Drug Interactions | Ribavirin - administration & dosage | Drug Therapy, Combination | Hepacivirus - drug effects | Proline - administration & dosage | Drug Eruptions - etiology | Antiviral Agents - pharmacology | Drug Administration Schedule | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Gastrointestinal Tract - drug effects | Treatment Outcome | Clinical Trials as Topic | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Interferon-alpha - administration & dosage | Proline - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Proline - adverse effects | Interferon-alpha - adverse effects | Oligopeptides - administration & dosage | Anemia, Hypochromic - chemically induced | Antiviral agents | Care and treatment | Protease inhibitors | Proteases | Immunodeficiency | Thrombin | Hepatitis C virus | HIV (Viruses) | Health aspects
Journal Article
Experimental and Toxicologic Pathology, ISSN 0940-2993, 2010, Volume 62, Issue 4, pp. 333 - 341
Journal Article
Blood, ISSN 0006-4971, 03/2009, Volume 113, Issue 12, pp. 2843 - 2850
The iron regulatory hormone hepcidin is transcriptionally up-regulated in response to iron loading, but the mechanisms by which iron levels are sensed are not... 
DANIO-RERIO | ANTIMICROBIAL PEPTIDE HEPCIDIN | HEREDITARY HEMOCHROMATOSIS PROTEIN | POSITIONAL CLONING | GENE | JUVENILE HEMOCHROMATOSIS | HFE | IN-VIVO | RECEPTOR | HEMATOLOGY | IRON OVERLOAD | Phenylhydrazines - toxicity | Species Specificity | Humans | Antimicrobial Cationic Peptides - biosynthesis | Embryo, Nonmammalian - metabolism | Molecular Sequence Data | Erythropoiesis - drug effects | Transferrin - physiology | Zebrafish - embryology | Embryo, Nonmammalian - drug effects | Transferrin - genetics | Gene Knockdown Techniques | Hepcidins - physiology | Anemia, Hypochromic - genetics | Cation Transport Proteins - genetics | Receptors, Transferrin - genetics | Antimicrobial Cationic Peptides - genetics | Iron - pharmacology | Erythropoiesis - genetics | Gene Expression Regulation, Developmental - physiology | Amino Acid Sequence | Zebrafish Proteins - biosynthesis | Hepcidins - biosynthesis | Transferrin - deficiency | Gene Expression Regulation, Developmental - drug effects | Organ Specificity | Iron - metabolism | Zebrafish Proteins - physiology | Anemia, Hypochromic - embryology | Sequence Homology, Amino Acid | Sequence Alignment | Zebrafish Proteins - deficiency | Animals | Hepcidins - genetics | Receptors, Transferrin - physiology | Hepcidins - deficiency | Anemia, Hypochromic - chemically induced | Mutation | Zebrafish Proteins - genetics | Receptors, Transferrin - antagonists & inhibitors | Index Medicus | Abridged Index Medicus | Red Cells, Iron, and Erythropoiesis
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 10/2010, Volume 66, Issue 10, pp. 1055 - 1063
The conventional antiviral treatment of chronic hepatitis related to hepatitis C virus (HCV) often leads to anemia. In this case, it is necessary to reduce... 
Genotype 1b HCV-related chronic hepatitis | Peg-interferon alpha-2A | Epoetin alpha | Biomedicine | Pharmacology/Toxicology | Ribavirin | PLUS RIBAVIRIN | COST-EFFECTIVENESS | INDUCED ANEMIA | SUSTAINED RESPONSE | GENOTYPE-1 | RIBAVIRIN COMBINATION THERAPY | INTERFERON-ALPHA | PEGINTERFERON ALPHA-2A | C VIRUS-INFECTION | GROWTH-FACTORS | PHARMACOLOGY & PHARMACY | Anemia, Hypochromic - drug therapy | Prospective Studies | Erythropoietin - therapeutic use | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | Recombinant Proteins | Viral Load | Ferritins - blood | Ribavirin - administration & dosage | Adult | Female | Epoetin Alfa | Drug Therapy, Combination | Hepacivirus - drug effects | Hepacivirus - isolation & purification | Drug Administration Schedule | Hematinics - therapeutic use | Hemoglobins - metabolism | RNA, Viral - analysis | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Quality of Life | Interferon-alpha - adverse effects | Anemia, Hypochromic - chemically induced | Longitudinal Studies | Anemia | Interferon alpha | Glycosylated hemoglobin | Drug therapy | Hepatitis C | Biological response modifiers | Hepatitis C virus | Patient compliance | Hepatitis | Genotype & phenotype | Pharmacology | Antiviral drugs | Epidemiology
Journal Article